Biogen revenue and financials
$223.27Change from previous close: −0.14%Absolute change: −$0.32
In the fiscal year ended December 2025, Biogen reported revenue of $9.89B (+2.22% year over year). Net income was $1.29B, a net margin of 13.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +2.22%
- 2025 vs 2024
- Net income growth
- −20.79%
- 2025 vs 2024
- Net margin
- 13.1%
- 2024: 16.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32,087 | 29,483 | 29,440 | 29,208 | 28,330 | 28,033 | 28,049 | 28,313 | 26,804 | 26,568 | 26,845 | 28,193 |
| Current assets | 7,306 | 9,190 | 8,974 | 8,937 | 7,968 | 7,626 | 7,457 | 6,831 | 7,109 | 6,756 | 6,859 | 8,454 |
| Cash and equivalents | 1,285 | 3,383 | 3,009 | 3,863 | 2,759 | 2,598 | 2,375 | 1,699 | 1,909 | 1,074 | 1,050 | 2,288 |
| Short-term investments | 0.0 | 900 | 807 | 97.6 | — | — | — | — | — | — | — | — |
| Receivables | 2,398 | 1,790 | 1,867 | 1,850 | 2,084 | 1,997 | 1,869 | 1,988 | 2,078 | 2,436 | 2,530 | 2,632 |
| Inventory | 2,384 | 1,949 | 2,168 | 2,209 | 2,274 | 2,274 | 2,461 | 2,469 | 2,506 | 2,517 | 2,527 | 2,982 |
| Net property, plant and equipment | 3,240 | 3,269 | 3,321 | 3,406 | 3,433 | 3,479 | 3,538 | 3,591 | 3,639 | 3,703 | 3,730 | 3,763 |
| Goodwill | 6,991 | 6,489 | 6,491 | 6,491 | 6,493 | 6,477 | 6,479 | 6,486 | 6,227 | 6,227 | 6,219 | 6,808 |
| Other intangible assets | 13,516 | 9,054 | 9,179 | 9,332 | 9,468 | 9,585 | 9,691 | 9,806 | 8,233 | 8,285 | 8,363 | 7,345 |
| Long-term investments | 594 | 1,011 | 955 | 486 | 407 | 394 | 424 | 353 | 352 | 564 | 626 | 656 |
| Current liabilities | 3,917 | 2,999 | 3,349 | 3,290 | 3,184 | 5,297 | 5,529 | 5,425 | 3,108 | 3,223 | 3,434 | 5,022 |
| Accounts payable | 404 | 359 | 432 | 413 | 408 | 392 | 424 | 423 | 355 | 387 | 403 | 440 |
| Long-term debt | 7,290 | 6,289 | 6,287 | 6,285 | 6,284 | 4,549 | 4,547 | 4,546 | 6,292 | 6,290 | 6,788 | 6,786 |
| Total debt | 8,355 | 6,562 | 6,577 | 6,590 | 6,595 | — | — | — | — | — | — | — |
| Total liabilities | 13,239 | 10,831 | 11,183 | 11,000 | 10,696 | 11,054 | 11,333 | 11,954 | 10,915 | 11,355 | 12,045 | 13,714 |
| Total equity (incl. minority) | 18,848 | 18,652 | 18,257 | 18,208 | 17,634 | 16,979 | 16,716 | 16,359 | 15,889 | 15,213 | 14,799 | 14,480 |
| Retained earnings | 20,970 | 20,872 | 20,553 | 20,602 | 20,135 | 19,500 | 19,260 | 18,993 | 18,605 | 18,021 | 17,628 | 17,378 |
| Minority interest | — | — | — | — | — | — | — | — | — | — | — | -4.1 |